Delivering Localized Trial Access.

EmVenio provides community-based clinical trial sites and patient-focused solutions that provide inclusive trial opportunities for diverse and underrepresented populations.

Request Information

Our innovative approach to patient empowerment and community engagement put the needs of patients and communities at the forefront. By breaking down barriers and creating opportunities for collaboration, we aim to create a more inclusive and supportive environment for all to participate in clinical trials, while simultaneously decreasing the risks and time associated with clinical research, leading to improving ROI.

Through the strategic establishment of clinical research sites in historically underserved regions, we can effectively reach patients who might otherwise go overlooked and underrepresented. With our comprehensive array of patient engagement initiatives, we are confident in our ability to connect the right individuals to the right clinical study, ultimately contributing to the advancement of medical research and the improvement of patient care.

EmVenio Research, now a PCM Trials company, is the largest independent DCT site network and the most experienced provider of local clinical trial access globally. Combined market leadership in mobile visits and clinical trial sites allows us to significantly improve participants’ overall experience in clinical trials.

Proven Results

Activated Sites

Protocols

Randomized Participants

%

Of Study Enrollment Targets Achieved

%

Of Enrolled Patients Self-Identified As Minority Ethnicity In Completed Studies

%

Retention Rate

Community Research Sites

Our sites are established in underrepresented communities with long term placement in mind and equipped to quickly activate on Sponsor’s new or existing studies.

EmVenio Research Center

Our full-service capabilities in community-based hospitals are situated in research naïve locations while fully supported by our experienced clinicians and expert PIs.